Search
Now showing items 1-2 of 2
Individualization of chronic hepatitis C treatment according to the host characteristics
(2014)
Hepatitis C virus (HCV) infection is a global health problem that affects more than 170 million people worldwide. It is a major cause of cirrhosis and hepatocellular carcinoma, making the virus the most common cause of ...
Adiponectin: a key playmaker adipocytokine in non-alcoholic fatty liver disease
(2014)
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and can progress to cirrhosis, liver failure, and hepatocellular carcinoma. In the last two decades, the prevalence of NAFLD has ...